HER2 Support Group Forums - View Single Post - First results from whole-genome sequencing clinical trial on triple negative breast c

News · 12-02-2011, 02:42 AM

Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin-(trastuzumab).

More...

12-02-2011, 02:42 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,721	First results from whole-genome sequencing clinical trial on triple negative breast c Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin-(trastuzumab). More...